Navigation Links
Safety and Efficacy Results Presented From Largest Prospective Controlled Clinical Study of Ulcerative Colitis
Date:5/20/2008

4.8 g/day dose using investigational 800 mg tablet demonstrated efficacy

and was well tolerated in ASCEND III study

SAN DIEGO, May 20 /PRNewswire-FirstCall/ -- In a study presented today at the 39th Annual Digestive Disease Week (DDW) meeting in San Diego, California, 70 percent of patients with moderately active ulcerative colitis (UC) receiving an investigational 800 mg mesalamine tablet dosed at 4.8 g/day under development by Procter & Gamble Pharmaceuticals experienced overall improvement in disease measures. In the study, the investigational tablet and dose were compared to 400 mg mesalamine tablets dosed at 2.4 g/day.

Additionally, patients in the study with a clinical history of more difficult-to-treat disease, such as those who have been previously treated with steroids and/or rectal therapies, received benefit from the investigational 800 mg tablets dosed at 4.8 g/day. Adverse events seen with the investigational 800 mg tablet dosed at 4.8 g/day were comparable to the 400 mg tablet dosed at 2.4 g/day and the discontinuation rate due to adverse events was no different between the two treatments (both 3.9 percent).

"The ASCEND III study is important because it helps us understand which patients may benefit from higher doses of mesalamine," says Dr. Stephen Hanauer, professor of medicine and clinical pharmacology chief, The University of Chicago Medical Center. "In this study the investigational 800 mg mesalamine tablet dosed at 4.8 g/day was well-tolerated and helped patients with moderately active UC manage their symptoms."

The ASCEND III study, which was discussed during an oral presentation at DDW today, was designed to further evaluate the clinical benefit of the investigational 800 mg tablet dosed at 4.8 g/day by assessing the non-inferiority of the 4.8 g/day dose versus the 2.4 g/day dose (400 mg mesalamine tablets). The primary endpoint was met -- the investigational 800 mg tablet dosed at 4.8 g/day w
'/>"/>

SOURCE Procter & Gamble
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. ADVENTRX Announces ANX-530 Safety Data From Registrational Bioequivalence Clinical Study
2. Alpharma Presents Data Addressing Abuse Liability Features, Safety and Efficacy on ALO-01 (EMBEDA(TM)) (morphine sulfate extended-release with sequestered naltrexone hydrochloride) at the American Pain Society Annual Scientific Session
3. Data Presented at the American Psychiatric Association (APA) Annual Meeting Demonstrate Iloperidones Efficacy and Safety, With Low Rates of Movement and Metabolic Adverse Events
4. Clinical Data Demonstrates 5-Year Efficacy and Safety of Aquamid(R) in Facial Augmentation
5. Nventa Completes Safety Evaluation on Final Cohort in HspE7 Phase 1 Cervical Dysplasia Trial
6. SurgiLance Safety Lancet Part of Major HIV Testing Initiative in Sub-Saharan Africa
7. Cardiac Safety Study of Stinger S-200 Published
8. Micromet Presents Safety and Efficacy Data from Primate Studies With Two New BiTE Antibodies Developed for Treatment of Leukaemia and Melanoma
9. VIA Pharmaceuticals Announces Updated DSMB Safety Results for VIA-2291 Ongoing Phase 2 Clinical Program
10. EnVivo Pharmaceuticals Announces Initiation of Clinical Safety and Biomarker Study of Alpha-7 Nicotinic Agonist, EVP-6124, in Patients with Schizophrenia
11. Final Data From the Bioheart Seismic Trial Suggest Safety, Efficacy of Autologous Stem-Cell Therapy for Treating Congestive Heart Failure
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/16/2014)... 16, 2014 This report analyzes the worldwide markets ... Segments: Parasiticides, Vaccines, Anti-Infectives, Medicinal Feed Additives, and Others. The ... Farm Animals. The report provides separate comprehensive analytics for the ... , Europe , Asia-Pacific ... World. Annual estimates and forecasts are provided for the period ...
(Date:9/16/2014)... , Sept. 16, 2014 The Pulmonary Fibrosis ... data from more than 1,100 patients and families suffering ... Drug Administration (FDA) for the Patient-Focused Drug Development Meeting ... a new FDA initiative to seek patient input in ... therapeutic treatments. "We applaud the FDA for ...
(Date:9/16/2014)...  This report analyzes the worldwide markets for Digital Radiography ... analytics for the US, Canada , ... Asia-Pacific , Middle East , ... Annual estimates and forecasts are provided for the period 2013 ... these markets. Market data and analytics are derived from primary ...
Breaking Medicine Technology:Global Animal Medication Industry 2Global Animal Medication Industry 3Global Animal Medication Industry 4Global Animal Medication Industry 5Global Animal Medication Industry 6Global Animal Medication Industry 7Global Animal Medication Industry 8Global Animal Medication Industry 9Global Animal Medication Industry 10Global Animal Medication Industry 11Global Animal Medication Industry 12Global Animal Medication Industry 13Global Animal Medication Industry 14Global Animal Medication Industry 15Global Animal Medication Industry 16Global Animal Medication Industry 17Global Animal Medication Industry 18Global Animal Medication Industry 19Global Animal Medication Industry 20Global Animal Medication Industry 21Global Animal Medication Industry 22Global Animal Medication Industry 23Global Animal Medication Industry 24Global Animal Medication Industry 25Global Animal Medication Industry 26PFF Submits Survey Data From More Than 1,100 Pulmonary Fibrosis Patients And Families To U.S. Food And Drug Administration For Upcoming Drug Development Meeting 2PFF Submits Survey Data From More Than 1,100 Pulmonary Fibrosis Patients And Families To U.S. Food And Drug Administration For Upcoming Drug Development Meeting 3PFF Submits Survey Data From More Than 1,100 Pulmonary Fibrosis Patients And Families To U.S. Food And Drug Administration For Upcoming Drug Development Meeting 4Global Digital Radiography Industry 2Global Digital Radiography Industry 3Global Digital Radiography Industry 4Global Digital Radiography Industry 5Global Digital Radiography Industry 6Global Digital Radiography Industry 7Global Digital Radiography Industry 8
... (NASDAQ: MASI ) today announced that in line ... Cost of Care by Taking Noninvasive Monitoring to New Sites ... (SpHb®) will further the company,s stated mission,  Masimo is introducing ... ransfusion R elated C ost R eduction ...
... JAZZ ) today announced that the company will host ... 2011 at 4:30 p.m. EST/9:30 p.m. GMT. During the call, ... quarter and full year 2011 financial results. The ... Investors section of the Jazz Pharmaceuticals, website at www.jazzpharmaceuticals.com ...
Cached Medicine Technology:Masimo Announces "Better Care" Program - A Hospital Risk-Share Program for Blood Transfusion Related Cost Reduction with SpHb®, and $30 SpHb Sensor Price 2Masimo Announces "Better Care" Program - A Hospital Risk-Share Program for Blood Transfusion Related Cost Reduction with SpHb®, and $30 SpHb Sensor Price 3Masimo Announces "Better Care" Program - A Hospital Risk-Share Program for Blood Transfusion Related Cost Reduction with SpHb®, and $30 SpHb Sensor Price 4Masimo Announces "Better Care" Program - A Hospital Risk-Share Program for Blood Transfusion Related Cost Reduction with SpHb®, and $30 SpHb Sensor Price 5Masimo Announces "Better Care" Program - A Hospital Risk-Share Program for Blood Transfusion Related Cost Reduction with SpHb®, and $30 SpHb Sensor Price 6Masimo Announces "Better Care" Program - A Hospital Risk-Share Program for Blood Transfusion Related Cost Reduction with SpHb®, and $30 SpHb Sensor Price 7
(Date:9/17/2014)... In honor of National Health IT Week Sept. ... professionals for gaining a competitive edge in the healthcare ... demand for qualified health IT professionals are at an ... differentiating factor when filling a position. The skill most ... clinical workflow and terminology experience. American Sentinel offers ...
(Date:9/17/2014)... September 17, 2014 Lee Berman, a ... will be appearing on The Balancing Act® airing on ... episodes. , The segment will premiere on September 19 ... Balancing Act® airing on Lifetime Television®' with show host ... Funding Corp. for over a decade and is the ...
(Date:9/17/2014)... Kingston, NY (PRWEB) September 17, 2014 ... style of wellness to the lineup at Techmanity, a ... as “the next generation of tech events,” Techmanity will ... Voom is excited to join the ranks of Cisco, ... this first ever Silicon Valley Technology Conference. , Voom ...
(Date:9/17/2014)... 17, 2014 Health.Verticalize, a healthcare marketing ... their health insurance options in the 2014 open enrollment ... , Moving forward Health Network will be ... company has intentionally remained out of the spotlight for ... a single website to its present position with dozens ...
(Date:9/17/2014)... Presence Technology, a multinational provider ... Suite 10.0, which incorporates significant enhancements to meet ... , The Contact Center Agents and Supervisors will ... get a better feel for the performance of ... and who requires additional coaching or mentoring to ...
Breaking Medicine News(10 mins):Health News:American Sentinel University Offers Tips to Health IT Professionals for Gaining Competitive Edge in the Job Market 2Health News:American Sentinel University Offers Tips to Health IT Professionals for Gaining Competitive Edge in the Job Market 3Health News:American Sentinel University Offers Tips to Health IT Professionals for Gaining Competitive Edge in the Job Market 4Health News:Lee Berman Will Appear On The Balancing Act® airing on Lifetime Television® 2Health News:Health and Wellness Startup Voom Announces Sponsorship at Techmanity 2Health News:Health.Verticalize Rebrands as Health Network After Growing to 15 Million Users in Less Than One Year 2Health News:Health.Verticalize Rebrands as Health Network After Growing to 15 Million Users in Less Than One Year 3Health News:Presence Technology’s 10.0 Release Drives Contact Center Web Supervisor Effectiveness While Reducing Operation Costs and Delivering Enterprise Grade Scalability 2
... AND INEFFECTIVE, NEW YORK, Oct. 29 ... using the most effective tool,to protect their players ... Chairman of the not-for-profit Committee to Reduce,Infection Deaths ... Today, RID is releasing a new 12-Step brochure ...
... points to globalization, drug resistance and climate change as ... least 170,000 Americans die each year from infectious diseases, ... disease outbreak. , That dire news was delivered in ... Diseases Are a Threat to America , released Wednesday ...
... Oct. 29 Pittsburgh-based Foundation,Radiology Group (FRG) signed ... FRG their exclusive provider of diagnostic,imaging services effective ... is located in Coudersport Pennsylvania,and services multiple counties ... The Hospital provides a wide range of primary ...
... straight to Caesarean section when delivering twins, but can start with ... found in a study led by UT Southwestern Medical Center. ... section, there is a slightly higher risk of infection for the ... risk of more serious complications for the second twin is not ...
... 29, 2008 Popular media coverage of infectious diseases greatly ... dangerous, according to a new study from McMaster University. , ... Science: ONE , suggests diseases that show up frequently in ... than similar diseases that do not receive the same kind ...
... Fla., Oct. 29 North Carolina-based Oaks,Development Group announced ... Park in Palm Coast, FL. Oaks will develop a ... Cary, NC handled the loan,closing for the project. Site ... the,year., Oaks is developing the 20,000-square-foot building using ...
Cached Medicine News:Health News:Professional Sports Teams Should Use MRSA Screening and Other Aggressive Methods to Prevent Staph Infections 2Health News:Threat From Infectious Diseases Growing 2Health News:Threat From Infectious Diseases Growing 3Health News:Foundation Radiology Group Announces Multi-Year Deal with Charles Cole Memorial Hospital 2Health News:Vaginal/Caesarean combo delivery of twins safe, UT Southwestern-led research finds 2Health News:Media coverage affects how people perceive threat of disease: study 2Health News:Oaks Development Group Closes on 2.1 Acres for Medical Office Building in Palm Coast, FL 2Health News:Oaks Development Group Closes on 2.1 Acres for Medical Office Building in Palm Coast, FL 3
... Quantel Medical Inc., the first to ... for ophthalmology, is proud to announce their ... solid-state green laser solves the problem that ... offices and operating rooms. No larger than ...
... all Gilson disposable pipette tips, ... sterilized version. Each Sterilized TowerPack ... device-quality plastic to help protect ... guaranteed by the red sticker, ...
This large orifice 1000 ul tips is the large volume alternative to MBP's 200G tip. Pipet fragile cells, viscous samples and genomic DNA with ease....
... in plastic-wrapped racks of 96 tips, Sterilized ... to autoclave. Sterilized Diamond Tips are irradiated ... are delivered with a certificate of sterilization, ... Tips are certified free of detectable Rnase, ...
Medicine Products: